Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Biolase, Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of BIOL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders2729+2
Shares5.31M4.44M−867.1K (−16.3%)
Value$1.49M$311.8K−$1.18M (−79.1%)

New holders (8)

Institutions that held Biolase, Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to BIOL in Q2 2023
InstitutionSharesValue% of portfolio
Walleye Capital LLC1,420,499$100.4K0.00%
Acadian Asset Management LLC961,739$67.0K0.00%
Avantax Planning Partners, Inc.544,053$38.5K0.00%
Millennium Management LLC406,759$28.8K0.00%
Two Sigma Securities, LLC160,934$11.4K0.00%
HRT Financial LP51,826$3.00K0.00%
Bank of Montreal34,000$2.85K0.00%
Cubist Systematic Strategies, LLC35,762$2.53K0.00%

Sold out (6)

Institutions that held Biolase, Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of BIOL in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
AWM Investment Company, Inc.1,938,571$545.1K
Renaissance Technologies LLC138,848$39.0K
Prudential Financial Inc58,800$16.5K
Orion Capital Management LLC2,000$562
Citigroup Inc1,994$561
Essex Investment Management Co LLC1$0